James Investment Research’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-125
| Closed | -$27K | – | 480 |
|
|
2023
Q1 | $27K | Hold |
125
| – | – | ﹤0.01% | 419 |
|
|
2022
Q4 | $26K | Sell |
125
-901
| -88% | -$187K | ﹤0.01% | 426 |
|
|
2022
Q3 | $224K | Sell |
1,026
-45
| -4% | -$9.83K | 0.03% | 246 |
|
|
2022
Q2 | $225K | Sell |
1,071
-10,269
| -91% | -$2.16M | 0.03% | 247 |
|
|
2022
Q1 | $2.75M | Sell |
11,340
-5,916
| -34% | -$1.43M | 0.29% | 90 |
|
|
2021
Q4 | $4.5M | Sell |
17,256
-266
| -2% | -$69.3K | 0.41% | 72 |
|
|
2021
Q3 | $4.62M | Buy |
17,522
+64
| +0.4% | +$16.9K | 0.43% | 71 |
|
|
2021
Q2 | $4.3M | Buy |
17,458
+561
| +3% | +$138K | 0.37% | 82 |
|
|
2021
Q1 | $3.28M | Buy |
16,897
+16,611
| +5,808% | +$3.22M | 0.3% | 98 |
|
|
2020
Q4 | $61K | Buy |
286
+69
| +32% | +$14.7K | 0.01% | 366 |
|
|
2020
Q3 | $37K | Buy |
+217
| New | +$37K | ﹤0.01% | 366 |
|